ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

ClinicalTrials.gov ID: NCT06807424

Public ClinicalTrials.gov record NCT06807424. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

Study identification

NCT ID
NCT06807424
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
750 participants

Conditions and interventions

Interventions

  • Icotrokinra Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 8, 2025
Primary completion
Feb 9, 2027
Completion
Oct 17, 2028
Last update posted
May 4, 2026

2025 – 2028

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
AARA Clinical Research Glendale Arizona 85306 Recruiting
AARA Clinical Research 1 Mesa Arizona 85210 Recruiting
Arthritis and Rheumatism Associates ARA Jonesboro Jonesboro Arkansas 72401 Recruiting
Clinical Research of West Florida Clearwater Florida 33765 Recruiting
Omega Research Consultants DeBary Florida 32713 Recruiting
Suncoast Clinical Research New Port Richey Florida 34652 Recruiting
Integral Rheumatology And Immunology Specialists Plantation Florida 33324 Recruiting
Clinical Research of West Florida 1 Tampa Florida 33606 Recruiting
Clinic of Robert Hozman Skokie Illinois 60076 Suspended
Klein And Associates M D P A Hagerstown Maryland 21740 Recruiting
DM Clinical Research 1 Brookline Massachusetts 02446 Completed
St Paul Rheumatology PA Eagan Minnesota 55123 Recruiting
Albuquerque Rehabilitation and Rheumatology Albuquerque New Mexico 87102 Recruiting
Joint and Muscle Research Institute Charlotte North Carolina 28204 Recruiting
Rheumatology Associates of Oklahoma Oklahoma City Oklahoma 73116 Recruiting
Altoona Center For Clinical Research Duncansville Pennsylvania 16635 Recruiting
Arthritis and Rheumatology Research Institute Allen Texas 75013 Recruiting
UT Southwestern Dallas Texas 75390 Recruiting
Naiara Alvarez MD Integrative Rheumatology of South TX Harlingen Texas 78550 Suspended
AARA Clinical Research Lone Star Arthritis and Rheumatology Irving Texas 75039 Recruiting
DM Clinical Research Tomball Texas 77375 Recruiting
Velocity Clinical Research Waco Texas 76710 Recruiting
Seattle Rheumatology Seattle Washington 98104 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 191 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06807424, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06807424 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →